Pre-Market: 5 stocks to watch out for today

The early indicator, SGX Nifty was at 6,239 up 13 points at 0830 hrs.

SI Reporter Mumbai
Last Updated : Mar 04 2014 | 8:46 AM IST
Markets are likely to make a flat opening tracking mixed global cues. The early indicator, SGX Nifty was at 6,239 up 13 points at 0830 hrs.

Benchmark share indices closed near their day's lows yesterday because of heightened political tensions between Russia and Ukraine.

US stocks tumbled on Monday alongside other risky assets globally as tensions in Ukraine and Russia escalated after Russian President Vladimir Putin declared he had the right to invade his neighbor.

Also Read

News that Ukraine mobilized for war on Sunday and Washington threatened to isolate Russia economically overshadowed better-than-expected U.S. data, including an index showing that factory activity rebounded from an eight-month low in February.

Asian shares were on the defensive on Tuesday as tensions over Ukraine showed no sign of abating, with Russia tightening its grip on Crimea while the West sought measures to deter Moscow.

Nikkei futures in Chicago pointed to a fall of about 0.4% in Tokyo shares following a 1.3% fall on Monday, while MSCI's broadest index of Asia-Pacific shares outside Japan sagged 0.1%.

As investors flocked to safe assets for fear of further escalation in geopolitical tensions, gold stood near a four-month high while the yield on US Treasuries yield dropped to a one-month low, reflecting higher prices for the bonds.

STOCKS TO WATCH

IDBI Bank plans to raise up to $300 million through Basel-III-compliant bonds by the end of March.

IOC has said it plans to acquire stakes in LNG terminals at Mundra and Dahej in Gujarat and Dighi in Maharashtra.

AstraZeneca Pharma India said it would delist from exchanges in the country, as asked by its Swedish promoter AstraZeneca Pharmaceuticals.

Oriental Bank of Commerce (OBC) today raised interest rates on fixed deposit of three maturities by up to 3.25%.

Sanofi has sued Glenmark over its generic drug filing on cardiac drug Multaq.

Tata Housing plans to invest Rs 1,200 crore by 2018 for setting up 13 such projects across the country.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 04 2014 | 8:33 AM IST

Next Story